Literature DB >> 797626

Adjuvant and antitumor activities of Nocardia cell-wall skeletons.

I Azuma, T Taniyama, M Yamawaki, K Sugimura, Y Yamamura.   

Abstract

The adjuvant activity of the cell-wall skeletons prepared from eight species (ten strains) of Nocardia was determined by Brunner's method using allogeneic cell-mediated cytotoxicity test. The antitumor activity of the cell-wall skeleton of N. rubra, which showed the most potent adjuvant activity, was examined using EL-4 leukemia and MH-134 hepatoma cells in syngeneic mice. Its results suggest that the cell-wall skeleton of N. rubra is more potent than BCG cell-wall skeleton as the immunotherapeutic agent for cancer immunotherapy in man. The chemical properties of the cell-wall skeleton of N. rubra were also described.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 797626

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


  13 in total

Review 1.  Immunomodulators isolated from microorganisms.

Authors:  Z Vanĕk; J Matĕjů; E Curdová
Journal:  Folia Microbiol (Praha)       Date:  1991       Impact factor: 2.099

2.  Randomized controlled study of postoperative adjuvant immunochemotherapy with Nocardia rubra cell wall skeleton (N-CWS) and Tegafur for gastric carcinoma.

Authors:  S Koyama; A Ozaki; Y Iwasaki; T Sakita; T Osuga; A Watanabe; M Suzuki; T Kawasaki; T Soma; T Tabuchi
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  Adjuvant activity of purified peptidoglycan of Listeria monocytogenes in mice and guinea pigs.

Authors:  I Saiki; K Kamisango; Y Tanio; H Okumura; Y Yamamura; I Azuma
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

4.  Adjuvant activity of synthetic 6-O-"mycoloyl"-N-acetylmuramyl-L-alanyl-D-isoglutamine and related compounds.

Authors:  I Azuma; K Sugimura; M Yamawaki; M Uemiya; S Kusumoto; S Okada; T Shiba; Y Yamamura
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

5.  Augmentative effect of Nocardia rubra cell-wall skeleton on the induction of human lymphokine-activated killer (LAK) cells by the production of LAK cell helper factor(s).

Authors:  T Shirasaka; I Kawase; M Okada; M Kitahara; T Ikeda; K Komuta; S Hosoe; S Yokota; T Masuno; S Kishimoto
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

6.  Adjuvant activity of 6-O-mycoloyl derivatives of N-acetylmuramyl-L-seryl-D-isoglutamine and related compounds in mice and guinea pigs.

Authors:  M Uemiya; K Sugimura; T Kusama; I Saiki; M Yamawaki; I Azuma; Y Yamamura
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

7.  Adjuvant activities of quinonyl-N-acetyl muramyl dipeptides in mice and guinea pigs.

Authors:  I Saiki; Y Tanio; M Yamawaki; M Uemiya; S Kobayashi; T Fukuda; H Yukimasa; Y Yamamura; I Azuma
Journal:  Infect Immun       Date:  1981-01       Impact factor: 3.441

8.  Antitumor effect of intrapleural administration of Lactobacillus casei in mice.

Authors:  T Matsuzaki; T Yokokura; M Mutai
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

9.  Augmentation of antitumor resistance by a strain of unicellular green algae, Chlorella vulgaris.

Authors:  K Tanaka; F Konishi; K Himeno; K Taniguchi; K Nomoto
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

10.  Enhancing effects of mini-cells prepared from Salmonella typhimurium on anti-tumor immunity in sarcoma 180-bearing mice.

Authors:  S Kurashige; S Mitsuhashi
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.